Schedule 13G ownership disclosure

ETERNA THERAPEUTICS INC

Common Stock, par value $0.005 per share · CUSIP: 114082209

Event date: 2024-10-29

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • John D. Halpern

    Shares: 5,136,581 · Class: 9.99%

  • Katherine H. Halpern

    Shares: 5,136,581 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-021705
Form type
SCHEDULE 13G/A
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Feb 14, 2025
Reporting period
Oct 29, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub